Carmona, Angelica V.
Jonnalagadda, Shirisha
Case, Alfie M.
Maddeboina, Krishnaiah
Jonnalagadda, Sravan K.
Dow, Louise F.
Duan, Ling
Penning, Trevor M.
Trippier, Paul C. http://orcid.org/0000-0002-4947-5782
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01 CA226436)
Article History
Received: 6 November 2023
Accepted: 11 April 2024
First Online: 29 April 2024
Competing interests
: P.C.T. and A.V.C. are inventors on a patent application describing the PROTAC compound. <i>‘AKR1C3 Targeted Heterobifunctional Small Molecule Proteolysis Targeting Chimeras’</i>. WO 2024/035780 A1. All other authors declare no competing interests.